title: Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States.
authors.forename: Kirk M
authors.initials: KM
authors.lastname: Chan-Tack
authors.forename: Arlene
authors.initials: A
authors.lastname: Gao
authors.forename: Amalia C
authors.initials: AC
authors.lastname: Himaya
authors.forename: Elizabeth G
authors.initials: EG
authors.lastname: Thompson
authors.forename: Mary E
authors.initials: ME
authors.lastname: Singer
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Uyeki
authors.forename: Debra B
authors.initials: DB
authors.lastname: Birnkrant
mesh_terms: D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D053243:Zanamivir / Q000627:therapeutic use*
chemical_list: D053243:Zanamivir